Patent ID: 11883128
Assignee: MIMOSA DIAGNOSTICS INC.
Field: Medical technology (Instruments)
Classification: CPC A  G | IPC A  G

Claim 5:
6. The method of claim 1, further comprising one or more of the following characteristics:
(a) the physiological markers for the marker maps comprise at least one of total hemoglobin, oxygen saturation, methemoglobin, water, and melanin;
(b) the marker map comprises a water marker map that is used for at least one of determining end points of resuscitation, monitoring burn edema, monitoring sepsis and monitoring infection:
(c) the marker map comprises a collagen marker map that is used to monitor at least one of wound healing, scar outcome and scar progression;
(d) the marker map comprises a melanin marker map that is used to monitor at least one of progression and regression of melanin deposition in skin, scar, and surrounding tissue;
(e) generating an alert when the analysis of the at least one marker map indicates a sudden change in the physiological condition;
(f) determining a relationship between at least two of the marker map; and analyzing the determined relationship to determine the composition of blood oxygenation and oxidation for the tissue region; and/or
(g) the processing comprises performing multispectral unmixing to generate the marker maps.